In Other News

• Stool Testing Predicts UTI Risk and Guides Antibiotic Selection

• Cystatin C Testing Helps Distinguish Abemaciclib Effect from Kidney Injury

• Rapid Host-Response Assay Gains FDA Clearance to Help Distinguish Bacterial and Viral Infections

• New Method Isolates Neuron-Linked Vesicles From Blood and Cerebrospinal Fluid

• Study Finds Potential Marker of Targeted Drug Resistance in Breast Cancer

• Review Highlights Progress and Validation Needs for AI in Digital Pathology

• Breakthrough-Designated Cytology Test Supports Oral Cancer Risk Assessment

• Collaboration Expands Access to Tests for Cancer Treatment Resistance and Toxicity Risk

• Blood Test Identifies Early Breast and Prostate Cancer Signals Years Before Diagnosis

• Blood-Based Score May Support Targeted Interventions for Healthier Aging

• Roche Gains FDA Clearance for Flexible Respiratory Pathogen Panel

• Noninvasive Tests Offer Alternatives to Biopsy for Assessing Advanced Liver Scarring

• Repeat Prenatal STI Screening and Treatment May Reduce Preterm Births

• Personal PCR Analyzer Aims to Enable At-Home Infectious Disease Testing

• Digital Twins Predict Treatment Response in Triple-Negative Breast Cancer

• Repeat Prenatal STI Screening and Treatment May Reduce Preterm Births

• Personal PCR Analyzer Aims to Enable At-Home Infectious Disease Testing

• Genetic Testing Offers Opportunities for Earlier Blood Disorder Carrier Identification

• Tumor and Immune Biomarkers Linked to Treatment Response in T-Cell Lymphoma

• Prototype Point-of-Care Lateral Flow Test Aims to Improve Neonatal Sepsis Triage

• Blood MRD Testing Aids Risk Analysis in Bladder and Other Cancers

• CE-Marked IVD Sequencing Platform Launches Across Ten EU Countries

• Liquid Biopsy Measures Tumor Burden and Identifies Small Cell Lung Cancer Subtypes